We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 3 2022/23.
Prescription Cost Analysis (PCA) provides details of the number of items and the net ingredient cost of all prescriptions dispensed in Northern Ireland. The drugs dispensed are listed by British National Formulary (BNF) ther…
Statistics on number of female patients of child bearing age prescribed Sodium Valproate.
Expected time taken to process and grant a marketing authorisation or a variation to a marketing authorisation.
An independent report to government from the Regulatory Horizons Council about the regulation of AI as a Medical Device.
An independent report to government from the Regulatory Horizons Council about the safe and rapid development of neurotechnology.
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 2 2022/23.
This PAR covers the assessment of the application to increase the pack size of Neutrogena T/Gel Therapeutic Shampoo to a maximum of 500ml as a GSL medicine.
A summary of the evidence on efficacy of Evusheld as a prophylactic treatment for coronavirus (COVID-19) considered by the RAPID C-19 Oversight Group.
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 1 2022/23.
This Public Assessment Report (PAR) covers the assessment of the proposal to add three new pack sizes (3, 4 & 6 cannisters) to the licence for Nicorette QuickMist 1mg/spray mouthspray and Nicorette QuickMist Smart Track …
This PAR covers the assessment of the proposal to make Sudafed Plus Blocked Nose 1mg/50mg/ml nasal spray solution, containing xylometazoline hydrochloride 1mg/ml (0.1% w/v) and dexpanthenol 50mg/ml (5% w/v), available throug…
This report presents key facts taken from the Family Practitioner Services annual reports in relation to activity and payment statistics within General Medical Services, Dentistry, Ophthalmic and Pharmaceutical Services in N…
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 4 2021/22.
Activity and payment statistics related to community pharmacy in Northern Ireland between April 2021 and March 2022.
The independent advisory group identified which patient groups are at highest risk of serious illness from COVID-19 and would benefit from new COVID-19 treatments.
This report presents activity and payment statistics related to Northern Ireland Community Pharmaceutical Services for quarter 3 2021/22.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).